Price difference as a predictor of the selection between brand name and generic statins in Japan》.pdf

Health Policy 119 (2015) 612–619 Contents lists available at ScienceDirect Health Policy j o u r na l h o me p a g e : w w w. elsev /locate/healthpol Price difference as a predictor of the selection between brand name and generic statins in Japan Osamu Takizawa, Hisashi Urushihara, Shiro Tanaka, Koji Kawakami ∗ Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Yoshidakonoe-cho, Sakyo-ku, Kyoto 606-8501,Japan a r t i c l e i n f o a b s t r a c t Article history: Objectives: This study aimed to explore the predictors of the selection between brand name Received 27 July 2014 drug (BR) and generic drug (GE) and to clarify the quantitative relationship about selection. Received in revised form 7 January 2015 Methods: We identified “incident users” who dispensed statins between April 2008 and Accepted 15 January 2015 June 2011 in commercially databases consisted of dispensing claims databases (DCD) of out-of-hospital pharmacies and hospital claims databases (HCD) of in-house pharmacies Keywords: in Japan. Predictors of the selection between BR and GE, including price difference (PD), Brand name drugs the price of BR, their interaction and percent change of the price of GE relative to BR were Generic drugs Price difference explored by logistic regression using DCD and HCD separately. Result